Gram-negative bacterial lipopolysaccharide lipid A (LPS lipid A)

Gram-negative bacterial lipopolysaccharide (LPS) lipid A is the highly conserved, hydrophobic anchor of the LPS molecule situated within the outer leaflet of the bacterial outer membrane (Raetz & Whitfield, 2002, Annual Review of Biochemistry). It is essential for the structural integrity and permeability barrier of Gram-negative bacteria, protecting them against harsh environmental conditions and certain antibiotics. Lipid A is also the primary immunostimulatory component of LPS, acting as a potent endotoxin that is recognized by the human Toll-like receptor 4 (TLR4)/MD-2 complex (Park et al., 2009, Nature). While this recognition is vital for initiating an innate immune response, an overabundance of lipid A in the systemic circulation can trigger a massive release of pro-inflammatory cytokines, leading to sepsis and septic shock (Opal, 2010, Journal of Infectious Diseases). Pharmacologically, lipid A is the target of cationic polypeptide antibiotics like polymyxins, which bind to its negatively charged phosphate groups to disrupt the membrane (Velkov et al., 2013, Journal of Medicinal Chemistry). Additionally, synthetic analogs of lipid A have been investigated as TLR4 antagonists to treat sepsis, though many have faced challenges in clinical trials.

Other names

EndotoxinLipid ALipopolysaccharideLipoglycan

Direct binding to the lipid A moiety to disrupt the bacterial outer membrane integrity or competitive inhibition of the TLR4/MD-2 receptor complex to prevent endotoxin-mediated inflammatory signaling.